boric acid has been researched along with Astrocytoma, Grade IV in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hacioğlu, C; Kaçar, S; Kar, F | 1 |
| Arslantas, A; Aydin, HE; Gunduz, MK; Kandemir, T; Kizmazoglu, C | 1 |
| Arslan, ME; Mardinoglu, A; Tatar, A; Turkez, H | 1 |
3 other study(ies) available for boric acid and Astrocytoma, Grade IV
| Article | Year |
|---|---|
The dual role of boron in vitro neurotoxication of glioblastoma cells via SEMA3F/NRP2 and ferroptosis signaling pathways.
Topics: Antioxidants; Boron; Cell Line, Tumor; Ferroptosis; Glioblastoma; Humans; Membrane Proteins; Nerve Tissue Proteins; Neuropilins; Oxidants; Semaphorins; Signal Transduction | 2023 |
Cytotoxic Effect of Boron Application on Glioblastoma Cells.
Topics: Boric Acids; Boron; Boron Neutron Capture Therapy; Brain Neoplasms; Cell Line, Tumor; Cytotoxins; Dose-Response Relationship, Drug; Glioblastoma; Humans | 2021 |
Promising potential of boron compounds against Glioblastoma: In Vitro antioxidant, anti-inflammatory and anticancer studies.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Borates; Boric Acids; Boron Compounds; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Glioblastoma; Humans; Inflammation Mediators | 2021 |